![Daniel Hume](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Hume
Director/Board Member at TG THERAPEUTICS, INC.
Net worth: 4 M $ as of 2024-06-29
Daniel Hume active positions
Companies | Position | Start | End |
---|---|---|---|
TG THERAPEUTICS, INC. | Director/Board Member | 2015-03-31 | - |
Independent Dir/Board Member | 2015-03-31 | - | |
New York State Bar Association
![]() New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Corporate Officer/Principal | - | - |
Kirby Mcinerney LLP
![]() Kirby Mcinerney LLP Miscellaneous Commercial ServicesCommercial Services Kirby McInerney LLP is a plaintiffs' law firm based in the United States that specializes in complex financial litigation and dispute resolution for institutional and individual clients. The private company is based in New York, NY. The company's areas of focus include securities, antitrust, whistleblower, and consumer litigation, among others. The firm has a successful track record in securities litigation, having recovered billions of dollars for shareholders. Kirby McInerney's website provides additional information about the firm. | Corporate Officer/Principal | 1994-12-31 | - |
Supreme Court of the United States | Corporate Officer/Principal | - | - |
United States District Court for the Southern District of NY | Corporate Officer/Principal | - | - |
United States District Court for the Eastern District of NY | Corporate Officer/Principal | - | - |
United States Court of Appeals for the Second Circuit | Corporate Officer/Principal | - | - |
United States Court of Appeals For The Fourth Circuit | Corporate Officer/Principal | - | - |
Daniel M. Hume, M.D. PA | President | - | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Career history of Daniel Hume
Former positions of Daniel Hume
Companies | Position | Start | End |
---|---|---|---|
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Daniel Hume
State University of New York at Albany | Undergraduate Degree |
Columbia Law School | Graduate Degree |
Statistics
International
United States | 15 |
Operational
Corporate Officer/Principal | 7 |
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 4 |
Government | 4 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
TG THERAPEUTICS, INC. | Health Technology |
Private companies | 11 |
---|---|
New York State Bar Association
![]() New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Commercial Services |
Kirby Mcinerney LLP
![]() Kirby Mcinerney LLP Miscellaneous Commercial ServicesCommercial Services Kirby McInerney LLP is a plaintiffs' law firm based in the United States that specializes in complex financial litigation and dispute resolution for institutional and individual clients. The private company is based in New York, NY. The company's areas of focus include securities, antitrust, whistleblower, and consumer litigation, among others. The firm has a successful track record in securities litigation, having recovered billions of dollars for shareholders. Kirby McInerney's website provides additional information about the firm. | Commercial Services |
National Holdings Corp.
![]() National Holdings Corp. Investment Banks/BrokersFinance National Holdings Corp. engages in the provision of investment banking and asset management services. It operates through the following segments: Brokerage and Advisory Services and Tax and Accounting Services. The Brokerage and Advisory Services segment includes broker-dealer and investment advisory services, sale of insurance products and licensed mortgage brokerage services. The Tax and Accounting Services segment involves tax preparation and accounting services provided by National Tax. The company was founded in 1947 and is headquartered in New York, NY. | Finance |
Stemline Therapeutics, Inc.
![]() Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY. | Health Technology |
Supreme Court of the United States | Government |
United States District Court for the Southern District of NY | Government |
United States District Court for the Eastern District of NY | Government |
United States Court of Appeals for the Second Circuit | |
United States Court of Appeals For The Fourth Circuit | |
Daniel M. Hume, M.D. PA | |
Lirum Therapeutics, Inc.
![]() Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Daniel Hume
- Experience